Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03269760 · ClinicalTrials.gov registry record · Phase 1
Multimodal Sleep Pathway for Shoulder Arthroplasty
A Phase 1 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 1
- Development phase
- 122
- Enrollment target
NCT03269760 is a Phase 1 study that has completed, run by University of California, San Francisco. The registered enrollment target is 122 participants.
The verdict
NCT03269760, a Phase 1 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 122 participants
- Enrollment target
Study Summary
The purpose of the study is to investigate the efficacy of sleep medicine in the recovery of orthopaedic shoulder arthroplasty patients. The investigators hypothesize that a multimodal sleep pathway including non-pharmacological sleep hygiene interventions and the use of zolpidem can improve patient sleep, pain control, and subsequent recovery after undergoing total shoulder arthroplasty.
Interventions
- DRUG Zolpidem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 122 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2020-02-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03269760
The ClinicalTrials.gov registry entry for NCT03269760 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 122 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zolpidem is the first listed.
NCT03269760 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03269760 about?
NCT03269760 is a clinical study titled "Multimodal Sleep Pathway for Shoulder Arthroplasty". The purpose of the study is to investigate the efficacy of sleep medicine in the recovery of orthopaedic shoulder arthroplasty patients. The investigators hypothesize that a multimodal sleep pathway including non-pharmacological sleep hygiene interventions and the use of zolpidem can improve patient...
What is the current status of trial NCT03269760?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 122 participants. The study started on 2017-09-01. Estimated completion is 2020-02-01.
What interventions are being tested in trial NCT03269760?
The interventions under investigation include: Zolpidem (DRUG).
Who is sponsoring clinical trial NCT03269760?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.